Search research articles
Contact Us
Filters
Showing results (241-250 of 471) with videos related to
Page
of 48
Sort By:
Journal of the American College of Cardiology
|
March 7, 2006
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction
Amir Halkin, Gregg W Stone, Cindy L Grines, et al.
The American Journal of Cardiology
|
October 30, 2003
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age
Ioannis Iakovou, George Dangas, Roxana Mehran, et al.
The American Journal of Cardiology
|
May 15, 2002
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries
Dale T Ashby, George Dangas, Roxana Mehran, et al.
Journal of the American College of Cardiology
|
February 25, 2014
Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS
Philippe Généreux, Mahesh V Madhavan, Gary S Mintz, et al.
The American Journal of Cardiology
|
July 17, 2007
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)
Steven P Marso, Todd Miller, Barry D Rutherford, et al.
The American Journal of Cardiology
|
January 21, 2011
Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial)
Robert J Applegate, Manejeh Yaqub, James B Hermiller, et al.
The New England Journal of Medicine
|
May 7, 2010
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease
Gregg W Stone, Ali Rizvi, William Newman, et al.
The New England Journal of Medicine
|
March 29, 2002
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
Gregg W Stone, Cindy L Grines, David A Cox, et al.
The American Journal of Cardiology
|
November 25, 2010
Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial
James C Blankenship, Kimberly A Skelding, Thomas D Scott, et al.
American Heart Journal
|
March 12, 2011
Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction
C Michael Gibson, Akiko Maehara, Alexandra J Lansky, et al.
Page
of 48
Search research articles
Search
Showing results (241-250 of 471) with videos related to
Sort By:
Page
of 48
Journal of the American College of Cardiology
|
March 7, 2006
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction
Amir Halkin, Gregg W Stone, Cindy L Grines, et al.
The American Journal of Cardiology
|
October 30, 2003
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age
Ioannis Iakovou, George Dangas, Roxana Mehran, et al.
The American Journal of Cardiology
|
May 15, 2002
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries
Dale T Ashby, George Dangas, Roxana Mehran, et al.
Journal of the American College of Cardiology
|
February 25, 2014
Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS
Philippe Généreux, Mahesh V Madhavan, Gary S Mintz, et al.
The American Journal of Cardiology
|
July 17, 2007
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)
Steven P Marso, Todd Miller, Barry D Rutherford, et al.
The American Journal of Cardiology
|
January 21, 2011
Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial)
Robert J Applegate, Manejeh Yaqub, James B Hermiller, et al.
The New England Journal of Medicine
|
May 7, 2010
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease
Gregg W Stone, Ali Rizvi, William Newman, et al.
The New England Journal of Medicine
|
March 29, 2002
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
Gregg W Stone, Cindy L Grines, David A Cox, et al.
The American Journal of Cardiology
|
November 25, 2010
Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial
James C Blankenship, Kimberly A Skelding, Thomas D Scott, et al.
American Heart Journal
|
March 12, 2011
Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction
C Michael Gibson, Akiko Maehara, Alexandra J Lansky, et al.
Page
of 48